Large epidemiological studies often require sample transportation and storage, presenting unique considerations when applying advanced lipidomics techniques. The goal of this study was to acquire lipidomics data on plasma and serum samples stored at potential preanalytical conditions (e.g., thawing, extracting, evaporating), systematically monitoring lipid species for a period of one month. Split aliquots of 10 plasma samples and 10 serum samples from healthy individuals were kept in three temperature-related environments: refrigerator, laboratory benchtop, or heated incubator. Samples were analyzed at six different time points over 28 days using a Bligh & Dyer lipid extraction protocol followed by direct infusion into a lipidomics platform using differential mobility with tandem mass spectrometry. The observed concentration changes over time were evaluated relative to method and inter-individual biological variability. In addition, to evaluate the effect of lipase enzyme levels on concentration changes during storage, we compared corresponding fasting and post-prandial plasma samples collected from 5 individuals. Based on our data, a series of low abundance free fatty acid (FFA), diacylglycerol (DAG), and cholesteryl ester (CE) species were identified as potential analytical markers for degradation. These FFA and DAG species are typically produced by endogenous lipases from numerous triacylglycerols (TAGs), and certain high abundance phosphatidylcholines (PCs). The low concentration CEs, which appeared to increase several fold, were likely mass-isobars from oxidation of other high concentration CEs. Although the concentration changes of the high abundant TAG, PC, and CE precursors remained within method variability, the concentration trends of FFA, DAG, and oxidized CE products should be systematically monitored over time to inform analysts about possible pre-analytical biases due to degradation in the study sample sets.
Keywords: 15-Hp-PGD2, 15-hydroperoxy-prostaglandin D2; CE, Cholesteryl ester; CER, Ceramide; Cholesteryl Ester; DAG, Diacylglycerol; Degradation; FFA, Free Fatty Acid; Fatty Acids; HpETE, hydroperoxyeicosatetraenoic acid; HpODE, hydroperoxyoctadecadienoic acid; Hydrolysis; LPC, Lysophosphatidylcholine; LPE, Lysophosphatidylethanolamine; Lipidomics; LysoPL, Lysophospholipid; Oxidation; PC, Phosphatidylcholine; PE, Phosphatidylethanolamine; PGD2, prostaglandin D2; PL, Phospholipid; PLA1, phospholipase A1; PLA2, phospholipase A2; SM, Sphingomyelin; Stability; TAG, Triacylglycerol; Triglycerides.